Custom Index Systems, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Custom Index Systems, LLC
- $186 Billion
- Q4 2024
A detailed history of Custom Index Systems, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Custom Index Systems, LLC holds 286 shares of REGN stock, worth $163,323. This represents 0.11% of its overall portfolio holdings.
Number of Shares
286
Previous 285
0.35%
Holding current value
$163,323
Previous $300 Million
32.0%
% of portfolio
0.11%
Previous 0.16%
Shares
5 transactions
Others Institutions Holding REGN
# of Institutions
1,497Shares Held
87MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.3 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.82 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.03 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.76 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.71 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $61.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...